MK0954, /Duration of Treatment : 5 Years

Phase 3

Phase 3

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Hypertension and Left Ventricular Hypertrophy (Thickening of the Main Pumping Chamber of the Heart)

Drug Information

Target Indication

Hypertension and Left Ventricular Hypertrophy (Thickening of the Main Pumping Chamber of the Heart)

Clinical Trial

Last updated: 1/2/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

CODX

Co-Diagnostics, Inc.

Related Pipeline

Hypercholesterolemia

Clostridium Difficile Infection

Osteoporosis, Postmenopausal

DLBCL

Sedation in Intensive Care